MAHMOODZADEGAN NAVID
SEC CIK 1604685 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MC | Moelis & Co | Co-Pres, MD, Dir | 207.0K | — | $26.69M | 18 | 2022-02-22 | 2025-02-19 |
Most active insiders at MC, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WATANABE OSAMU R. | GC, Sec | — | $508.2K |
| 2 | Shropshire Kenneth | Dir | — | $129.9K |
| 3 | Barker Thorold | Dir | — | — |
| 4 | Riehl Nick | Principal Accounting Off | — | — |
| 5 | Mirrer Louise | Dir | — | — |
| 6 | Pilcher Ciafone Katherine | COO | — | — |
| 7 | Worrell Laila | Dir | — | — |
| 8 | Callesano Christopher | CFO | — | — |
| 9 | Cantor Eric | Vice COB, MD, Dir | — | — |
| 10 | MOELIS KENNETH | Executive COB, Dir | — | — |
MAHMOODZADEGAN NAVID made no open-market trades at MC in the last 12 months.
Transactions 18
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-21 | 2025-02-19 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD | F - Tax | $74.00 | -0.98 | 207.0K | -0.0% | -$72.52 |
| D | 2025-02-21 | 2025-02-19 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD | S - Sale+OE | $74.00 | -9,406 | 197.6K | -5% | -$696.0K |
| D | 2025-02-21 | 2025-02-19 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD | M - OptEx | — | +57.0K | 207.0K | +38% | — |
| D | 2025-02-20 | 2025-02-18 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD | M - OptEx | — | +150.0K | 150.0K | New | — |
| 2024-05-14 | 2024-05-13 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD | S - Sale | $54.92 | -45.0K | 0 | -100% | -$2.47M | |
| M | 2024-03-01 | 2024-02-29+ | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD | S - Sale | $54.05 | -70.3K | 45.0K | -61% | -$3.80M |
| DM | 2024-02-23 | 2024-02-21 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD | M - OptEx | — | +177.6K | 211.5K | +524% | — |
| D | 2024-02-23 | 2024-02-21 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD | F - Tax | $52.60 | -1.10 | 211.5K | -0.0% | -$57.86 |
| DM | 2024-02-23 | 2024-02-21+ | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD | S - Sale+OE | $52.85 | -96.3K | 115.2K | -46% | -$5.09M |
| M | 2024-02-21 | 2024-02-16+ | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD | S - Sale | $55.26 | -66.0K | 54.2K | -55% | -$3.64M |
| 2023-03-07 | 2023-03-03 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD, Dir | S - Sale | $43.05 | -23.3K | 99.9K | -19% | -$1.00M | |
| M | 2023-03-02 | 2023-02-28+ | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD, Dir | S - Sale | $43.17 | -106.2K | 123.2K | -46% | -$4.59M |
| D | 2023-02-24 | 2023-02-22 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD, Dir | F - Tax | $42.06 | -19.2K | 237.1K | -8% | -$809.3K |
| DM | 2023-02-24 | 2023-02-22 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD, Dir | M - OptEx | — | +171.4K | 256.4K | +202% | — |
| D | 2023-02-24 | 2023-02-22 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD, Dir | S - Sale+OE | $42.06 | -68.6K | 229.4K | -23% | -$2.88M |
| D | 2022-02-24 | 2022-02-22 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD, Dir | S - Sale+OE | $47.12 | -53.5K | 145.8K | -27% | -$2.52M |
| D | 2022-02-24 | 2022-02-22 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD, Dir | F - Tax | $47.12 | -10.8K | 199.3K | -5% | -$510.8K |
| D | 2022-02-24 | 2022-02-22 | MC | Moelis & Co | MAHMOODZADEGAN NAVID | Co-Pres, MD, Dir | M - OptEx | — | +133.8K | 210.2K | +175% | — |
Purchase Sale Sale after option exercise All abbreviations